Related Experiment Video
Updated: Jul 20, 2026

Venous Thrombosis Assay in a Mouse Model of Cancer
Published on: January 5, 2024
Nonpalpable purpura within a setting of anticoagulant therapy and metastatic carcinoma
Nicole Grenier1, Catherine Chen-Tsai
1Department of Dermatology and Skin Surgery, Roger Williams Medical Center, Providence, RI, USA.
Abstract:
The anticoagulant warfarin can produce a skin necrosis that is clinically indistinguishable from the skin necrosis caused by purpura fulminans associated with disseminated intravascular coagulation (DIC) and heparin-induced thrombocytopenia (HIT). The similar clinical and histologic findings observed in each of these skin necroses create a challenge for diagnosis and eventual treatment. The authors report a patient with significant risk factors for warfarin-induced skin necrosis, DIC, and HIT presenting with painful, purpuric patches beginning on her feet and extending proximally before becoming hemorrhagic bullae on her lower extremities.
Related Concept Videos
Venous Thrombosis III: Interprofessional Care
Venous Thrombosis IV: Nursing Management
Disorders of Hemostasis
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Metastasis
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies
Peptic Ulcer
